Real-world efficacy and safety of trifluridine/tipiracil plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies

被引：0
|
作者：
Martinez Lago, N. [1 ]
Alonso de Castro, B. [2 ]
Varela Ponte, R. [3 ]
Reboredo Rendo, C. [2 ]
Gomez-Randulfe Rodriguez, M. [2 ]
Grana Suarez, B. [4 ]
de la Camara Gomez, J. [2 ]
Mateos Salvador, M. [2 ]
Busto Fernandez, F. [2 ]
Calleja Chucla, T. [2 ]
Reboredo-Lopez, M. [2 ]
机构：
[1] Complejo Hosp Univ, La Coruna, Spain
[2] Univ Hosp A Coruna, La Coruna, Spain
[3] Complejo Hosp Univ Santiago, Santiago De Compostela, A Coruna, Spain
[4] Complejo Hosp Univ A Coruna, Inst Invest Biomed INIBIC, La Coruna, Spain
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.086
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-31
引用
收藏
页码：S106 / S107
页数：2
相关论文
共 50 条
  • [11] The Efficacy and Safety of Trifluridine/Tipiracil Treatment for Elderly Patients With Metastatic Colorectal Cancer in a Real-world Setting
    Shibutani, Masatsune
    En, Wang
    Okazaki, Yuki
    Kashiwagi, Shinichiro
    Fukuoka, Tatsunari
    Iseki, Yasuhito
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2021, 41 (12) : 6211 - 6216
  • [12] Safety and efficacy of trifluridine/tipiracil (TAS-102) plus bevacizumab in clinical practice for patients with refractory metastatic colorectal cancer
    Kotani, D.
    Kuboki, Y.
    Yasuda, K.
    Nakamura, Y.
    Kawazoe, A.
    Bando, H.
    Taniguchi, H.
    Shitara, K.
    Yoshino, T.
    ANNALS OF ONCOLOGY, 2018, 29 : 34 - 34
  • [13] Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospective study
    Chida, Keigo
    Kotani, Daisuke
    Nakamura, Yoshiaki
    Kawazoe, Akihito
    Kuboki, Yasutoshi
    Shitara, Kohei
    Kojima, Takashi
    Taniguchi, Hiroya
    Watanabe, Jun
    Endo, Itaru
    Yoshino, Takayuki
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [14] Real-World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
    Patel, Anuj K.
    Barghout, Victoria
    Yenikomshian, Mihran A.
    Germain, Guillaume
    Jacques, Philippe
    Laliberte, Francois
    Duh, Mei S.
    ONCOLOGIST, 2020, 25 (01): : E75 - E84
  • [15] Real-world experience on the efficacy and tolerability of biweekly trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer.
    Ang, Choon Seong
    Low, Qin Jian
    Ho, Carol Lf
    Walsh, Robert John
    Asokumaran, Yugarajah
    Choo, Joan Re
    Chan, Gloria Hj
    Ho, Jingshan
    Ang, Yvonne
    Tan, Hon Lyn
    Yong, Wei-Peng
    Sundar, Raghav
    Chee, Cheng Ean
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [16] Real-world use of trifluridine/tipiracil for patients with metastatic colorectal cancer in Canada
    Samawi, H. H.
    Brezden-Masley, C.
    Afzal, A. R.
    Cheung, W. Y.
    Dolley, A.
    CURRENT ONCOLOGY, 2019, 26 (05) : 319 - +
  • [17] Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
    Prager, Gerald W.
    Taieb, Julien
    Fakih, Marwan
    Ciardiello, Fortunato
    Van Cutsem, Eric
    Elez, Elena
    Cruz, Felipe M.
    Wyrwicz, Lucjan
    Stroyakovskiy, Daniil
    Papai, Zsuzsanna
    Poureau, Pierre-Guillaume
    Liposits, Gabor
    Cremolini, Chiara
    Bondarenko, Igor
    Modest, Dominik P.
    Benhadji, Karim A.
    Amellal, Nadia
    Leger, Catherine
    Vidot, Loick
    Tabernero, Josep
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (18): : 1657 - 1667
  • [18] Real-world evidence of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer using an administrative claims database in Japan
    Kagawa, Y.
    Shinozaki, E.
    Okude, R.
    Tone, T.
    Kunitomi, Y.
    Nakashima, M.
    ESMO OPEN, 2023, 8 (04)
  • [19] Frequency and management of trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV)-associated neutropenia in patients with refractory metastatic colorectal cancer (mCRC) in real-world practice
    Lago, N. Martinez
    Rendo, C. Reboredo
    Chucla, T. Calleja
    Salvador, M. Mateos
    Fernandez, F. Busto
    Gomez, J. de la Camara
    Reboredo-Lopez, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S100 - S101
  • [20] A real-world comparison of trifluridine/tipiracil and regorafenib in refractory metastatic colorectal cancer in the United States
    Nevala-Plagemann, Christopher Duane
    Ying, Jian
    Sama, Shashank
    Florou, Vaia
    Haaland, Benjamin
    Garrido-Laguna, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
12345